Loading...
Assessing quality of life on the day of chemotherapy administration underestimates patients’ true symptom burden
BACKGROUND: In chemotherapy trials quality of life (QOL) is assessed mostly at the days of chemotherapy administration (i.e. event-driven) during treatment and follows fixed time intervals in the aftercare phase (i.e. time-driven). Specific QOL impairments and treatment side-effects are known to be...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4198707/ https://ncbi.nlm.nih.gov/pubmed/25305067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-758 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|